Highland Capital Management (Texas)’s Alder Biopharmaceuticals ALDR Stock Holding History

Highland Capital Management (Texas)’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100,000	Closed	-$1.23M	–	364
2017 Q3	$1.23M	Buy	+100,000	New	+$1.04M	0.05%	179
2017 Q1	–	Sell	-81,000	Closed	-$1.69M	–	340
2016 Q4	$1.69M	Sell	81,000 -84,000	-51%	-$2.18M	0.08%	148
2016 Q3	$5.41M	Sell	165,000 -11,700	-7%	-$356K	0.17%	116
2016 Q2	$4.41M	Buy	176,700 +51,700	+41%	+$1.4M	0.18%	125
2016 Q1	$3.06M	Buy	+125,000	New	+$2.89M	0.14%	140

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Highland Capital Management (Texas)'s ALDR Position: Q4 2017 in Review

Highland Capital Management (Texas) sold out of Alder Biopharmaceuticals (ALDR) in Q4 2017, closing a stake of 100,000 shares — an estimated $1.23M sold.

Highland Capital Management (Texas) first reported a position in ALDR in Q1 2016 and held it in 5 quarters. The position peaked at $5.41M in Q3 2016. 140 funds tracked by Wall St. Rank hold ALDR as of Q4 2017.

Highland Capital Management (Texas) reported no remaining Alder Biopharmaceuticals position as of Q4 2017 after selling out during the quarter.
Highland Capital Management (Texas) sold 100,000 Alder Biopharmaceuticals shares in Q4 2017, an estimated $1.23M.
Highland Capital Management (Texas) first reported a position in Alder Biopharmaceuticals in Q1 2016 and held it in 5 quarters.
Highland Capital Management (Texas)'s Alder Biopharmaceuticals position peaked at $5.41M in Q3 2016.
140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2017, filed 14 Feb 2018.